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ABSTRACT
Physical activity, be it regular exercise or sports at 
whatever level, should be beneficial and not deleterious. 
Hence, it is important that the medical profession is 
aware that cardiovascular related deaths are the leading 
cause of mortality in athletes during sports. In 2009 the 
International Olympic Committee issued a consensus 
statement on the periodic health evaluation of elite 
athletes. This includes ‘a comprehensive assessment of the 
athlete’s current health status and risk of future injury or disease 
and, typically, is the entry point for medical care of the athlete’. 
Although this consensus statement targeted elite athletes, 
the periodic health evaluation design is simple enough 
that it could easily be extrapolated for use for all physically 
active individuals. The periodic health evaluation’s role 
is to screen for musculoskeletal or medical conditions 
that may place an athlete at risk for safe participation. 
Since this statement was issued, numerous international 
sport organisations have recommended a screening 
programme for individuals who partake in regular 
physical activity. Stress is made on the importance of a 
thorough health and family history with an emphasis on 
cardiovascular issues. There is no international consensus 
on the use of an electrocardiogram (ECG) as part of 
a screening programme; however most international 
sports federations and the European Cardiac and Sports 
Medicine societies strongly recommend it. What there is 
agreement on is that the doctor that reads an ECG should 
be knowledgeable of the physiological adaptations of 
the athletic heart that could lead to errant, yet perfectly 
safe, ECG traces.
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INTRODUCTION
The role regular physical activity has in the maintenance 
of a healthy lifestyle is well documented (The Lancet, 
2012 and 2016). In fact the following quotes are often 
circulated to show the importance physicality has always 
held:
•	 Hippocrates, 5th	century	BC:	“if	one	exercised	they	
become more healthy, well-developed and age 
more slowly”;
•	 Herodotus,	440	BC:	“if	we	could	give	every	
individual the right amount of nourishment and 
exercise, not too little and not too much, we would 
have found the safest way to health”;
•	 Plato,	472	BC:	“lack	of	activity	destroys	the	good	
condition of every human being, while movement 
and methodical physical exercise correctly save it 
and preserve it”.
However, physical activity, be it regular exercise or 
sports at whatever level, should be healthy and not 
deleterious. Hence it is important that the medical 
profession is aware that cardiovascular-related deaths are 
the leading cause of mortality in athletes during sports 
(Maron, et al., 2009; Harmon, et al., 2011). At the same 
time one must also not forget that musculoskeletal (MSK) 
issues go hand in hand with regular physical activity and 
even more so with contact sports (Ekstrand, Hägglund 
and Waldén, 2011). Although these are rarely fatal, they 
can have a significant effect on activities of daily living. 
Therefore, pre-participation screening is universally 
supported to identify athletes with pre-existing conditions 
that place them at risk of injury or an adverse cardiac event.
This paper shall focus primarily on what is 
recommended as a minimum requirement for the 
cardiovascular screening of an athlete, with MSK 
screening tackled in a future paper. It shall broach the 
subject by looking into the recommendations of the more 
established and recognised governing sporting authorities, 
namely the International Olympic Committee (IOC) and 
the Fédération Internationale de Football Association 
(FIFA), and the leading Sports and Exercise Medicine 
authorities in Europe and worldwide, specifically the 
European Federation of Sports and Exercise Medicine 
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(EFSMA), American College of Sports Medicine (ACSM) 
and the International Federation of Sports Medicine 
(FIMS). This paper shall not dwell on the myriads of 
documents that led to these recommendations, but rather 
view them in the local Maltese scenario.
INTERNATIONAL RECOMMENDATIONS
In 2009 the IOC issued a consensus statement on 
the periodic health evaluation (PHE) of elite athletes 
(Ljungqvist, et al., 2009). This includes ‘a comprehensive 
assessment of the athlete’s current health status and risk 
of future injury or disease and, typically, is the entry point 
for medical care of the athlete’. Although this consensus 
statement targeted elite athletes, the PHE design is 
simple enough that it could easily be extrapolated for 
use for all physically active individuals. The PHE’s role 
is to screen for MSK or medical conditions that may 
place an athlete at risk for safe participation. In fact the 
athlete may not even be aware that there is something 
wrong until this is revealed during a PHE. Alternatively, 
the athlete might have a current health problem and the 
PHE will serve to ensure that the medical ailment is being 
managed correctly and that the athlete is capable of safely 
undertaking physical activity at that particular moment. 
Amazingly, even athletes that have easy access to medical 
care sometimes choose to ignore, for whatever reasons, 
ailments that are causing significant symptoms. Other 
times, common asymptomatic conditions, such as a 
mild iron deficiency, may influence physical performance 
although the health of the athlete is not compromised. 
Ideally the PHE is undertaken early enough such that it 
allows sufficient time for the management of any injuries 
or medical problems that might be uncovered without 
affecting the athlete’s season too much.
Periodic health evaluation requirements
According to the IOC, the general requirements 
of a PHE include:
•	 Based	on	sound	scientific	and	medical	criteria.
•	 Be	performed	in	the	primary	interest	of	the	athlete.
•	 Under the responsibility of a physician trained 
in sports medicine, preferably the physician 
responsible for providing ongoing medical care for 
the athlete, e.g. the team physician. 
•	 The setting of the evaluation should be chosen 
to optimize the accuracy of the examination and 
respect the privacy of the athlete.
•	 Free and informed consent of the athlete and, if 
applicable, his/her legal guardian.
If the PHE provides evidence that an athlete is 
at serious medical risk, the physician must strongly 
discourage the athlete from continuing training or 
competing until the necessary medical measures have 
been	taken.	Based	on	such	advice,	it	is	the	responsibility	
of the athlete to decide whether to continue training or 
competing.
If a physician is requested to issue a medical 
certificate, he or she must have explained in advance to 
the athlete the reason for the PHE and its outcome, as well 
as the nature of information provided to the third parties.
With the advent of many non-local athletes and 
the organisation of sports for all ages and physical 
capabilities, the PHE should be tailored to race, age, 
gender and be sport specific. Cultural sensitivities 
should also be considered. Once an injury or medical 
condition is identified, if deemed necessary, a referral 
should be organised to the appropriate specialist for 
further evaluation and management. The PHE is also 
an opportunity to assess any medications or nutritional 
products being used to determine if a Therapeutic Use 
Exemption (TUE) application to the World Anti Doping 
Association (WADA) is required.
Periodic health evaluation form
The PHE consists of a five-page document divided into 
two sections: the medical history section and the physical 
examination section (International Olympic Committee, 
2009). The first section is thorough with an emphasis 
on elucidating any symptoms, signs or family history 
that could indicate an underlying cardiovascular issue. 
This cardiovascular focus is also seen in the physical 
examination section. This emphasis on cardiovascular 
evaluation of an athlete is stressed again since a 12 lead 
ECG is also required as part of a standard PHE. These 
all indicate how the prevention of sudden cardiac death 
in athletes remains a highly visible topic in sports and 
exercise medicine and cardiology.
When one is reviewing an ECG of an individual that 
regularly partakes in physical activity, one must note 
the cardiac adaptation and remodelling that regular 
physical training produces, which lead to common ECG 
alterations that could be mistaken as abnormal. Here the 
‘Seattle Criteria’ document comes in handy as this is the 
outcome of the collaboration between a number of sports 
and exercise medicine organisations to tackle this ECG 
interpretation predicament (Drezner, et al., 2013). In 
fact, nowadays one can even acquire commercial ECG 
machines that have ‘athlete specific’ software based on 
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the Seattle Criteria to assist in the interpretation of the 
results. However, it is still highly recommended that 
physicians responsible for the medical care of athletes 
be guided by ECG interpretation standards that improve 
disease detection and limit false-positive results. Here one 
must stress again the recommendation by the IOC who 
encourages a referral to a specialist in the field, ideally a 
cardiologist attuned to the athletic heart, whenever there 
are any doubts.
To assist medical professionals that often have to 
deal with athletes, a number of free online courses have 
been created that tackle specifically ECG interpretation 
in	 athletes.	 Good	 examples	 are	 the	 British	Medical	
Journal learning course: ECG interpretation in athletes 
(British	Medical	 Journal,	 2017)	 and	 the	FEMEDE	 -	La	
Sociedad Espanola de Medicina Del Deporte - course: 
Electrocardiography for sports medicine (FEMEDE, 2017).
The FIFA Pre-competition Medical Assessment 
(PCMA) (Dvorak, et al., 2009: Corrado, et al., 2010) 
follows the PHE of the IOC and involves a focused player 
medical history (PMH), family medical history (FMH) 
and cardiac specific physical medical examination. FIFA 
insists that a resting 12-lead ECG should be undertaken 
as part of the PCMA on all players at the beginning of 
their playing career and then once every year. (Dvorak et 
al 2013). However, different to the IOC PHE, the PCMA 
recommends that echocardiography be considered at 
least once in a player’s early career to better detect 
structural disorders and should be undertaken by 
an experienced cardiologist and whenever abnormal 
results are found in the history, examination and/or 
ECG (Kramer, 2010). FIFA also recommends that an 
exercise test should be considered in athletes older than 
35 years of age and when otherwise indicated. EFSMA 
issued a statement in 2015 indicating that without the 
ECG, athletic medical screening has low sensitivity and 
will also likely have a very low specificity (Löllgen, et 
al., 2015). This statement has recently been supported 
by a meta-analysis (fifteen papers) showing that ECG in 
athletes “ is 5 times more sensitive than history, 10 times 
more sensitive than physical exam, has higher positive” 
and “lower negative likelihood ratio” with a “lower false 
positive rate” (Harmon, Zigman and Drezner, 2015).
LOCAL SCENARIO
In Malta the two larger non-governmental sports 
organisations, namely the Malta Football Association and 
the Maltese Olympic Committee, follow the lead of their 
parent organisations (FIFA and IOC), and require that 
athletes participating in their tournaments or games have 
a 12 lead ECG as part of their medical screening and that 
the physicians that conduct the medical screening have 
a sound knowledge of Sports and Exercise Medicine and 
ECG interpretation.
However, here one must note that not all Sports and 
Exercise Medicine organisations believe in the need of 
the ECG and the Joint Consensus Statement between 
the American College of Sports Medicine (ACSM) and 
the International Federation of Sports Medicine (FIMS) 
‘Advancing the Preparticipation Physical Evaluation 
(PPE)’ is an example of this (Roberts, Löllgen and 
Matheson, 2014). The ACSM and FIMS did not reach a 
consensus on ECG screening as a routine part of PPE, but 
agreed that a history and physical examination focusing 
on cardiac risk is essential, and an ECG should be used 
where risk is increased.
CONCLUSION
A thorough medical evaluation is a must prior to 
commencing any form of regular physical activity, be 
the athlete a weekend warrior, a walker or a professional 
athlete. The minimum requirements for recreational 
athletes are a detailed history and physical examination 
focusing on cardiac risk; an ECG should be used when 
the perceived risk is increased. For competitive athletes, 
a 12 lead ECG is not only recommended but might 
even be an essential sport federation requirement for 
participation. Ideally the physician undertaking the 
medical screening is familiar with the sport concerned 
and with its specific physical requirements. Maltese 
general practitioners that work with athletes can avail 
themselves of the aforementioned online ECG courses 
and have in place an appropriate referral procedure for 
any queries that might. The goal is that, one day, Malta 
will have the same legal requirement that is found in 
other countries, such as Italy, where all individuals that 
undertake physical activity in an organised fashion, be it 
as a member of a fitness club, a sport club or participation 
in sporting events, such as road races, must undertake a 
pre-participation health evaluation that will include an 
ECG and ideally this is undertaken with physicians that 
have undergone the appropriate training.
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